R01CA276652 (OLOPADE, OLUFUNMILAYO F.)Aug 11, 2023 - Jul 31, 2028 NIH Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA) Role: Co-Principal Investigator |
|
UT2CA244056 (OTO, AYTEKIN)Apr 1, 2020 - Jun 30, 2024 NIH MRI Virtual Pathology of the Prostate: Multi-center multi-vendor application and validation Role: Co-Principal Investigator |
|
R41CA244056 (OTO, AYTEKIN)Apr 1, 2020 - Mar 31, 2021 NIH MR Virtual Pathology of the Prostate Role: Co-Principal Investigator |
|
R01CA228036 (OTO, AYTEKIN)Apr 3, 2019 - Mar 31, 2025 NIH Detection of prostate Cancer Specific Signals with Hybrid Multi-Dimensional MRI Role: Co-Principal Investigator |
|
R01CA218700 (KARCZMAR, GREGORY S)Jun 15, 2017 - May 31, 2022 NIH Breast Cancer Screening with Quantitative Ultra-Fast DCEMRI and Clinical Risk Assessment Role: Principal Investigator |
|
S10OD018448 (KARCZMAR, GREGORY S)Jul 15, 2014 - Dec 14, 2016 NIH 3T MRI Scanner for multidisciplinary imaging and image-guided therapy Role: Principal Investigator |
|
R01CA172801 (KARCZMAR, GREGORY S)Aug 1, 2013 - May 31, 2019 NIH Quantitative DCEMRI of Prostate Cancer Correlation with Gold Standards Role: Principal Investigator |
|
R01CA167785 (KARCZMAR, GREGORY S)Feb 8, 2013 - Jan 31, 2020 NIH Assessment of Breast Cancer Risk with High Spectral and Spatial Resolution MRI Role: Principal Investigator |
|
R21EB015023 (KARCZMAR, GREGORY S)Aug 1, 2012 - Jul 31, 2015 NIH In Vivo Measurements of Physiologically-evoked Neuronal Currents Role: Principal Investigator |
|
R01CA133490 (KARCZMAR, GREGORY S)Mar 1, 2011 - Dec 31, 2016 NIH MRI of Early Non-invasive Rodent Mammary Cancers Role: Principal Investigator |
|
U01CA142565 (YANKEELOV, THOMAS E)May 1, 2010 - Aug 31, 2021 NIH Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy Role: Co-Principal Investigator |
|
R33CA100996 (KARCZMAR, GREGORY S)Sep 20, 2007 - Aug 31, 2011 NIH Microvessel Density With High Spectral/Spatial MRI Role: Principal Investigator |
|
S10RR021177 (KARCZMAR, GREGORY S)May 15, 2006 - May 14, 2007 NIH A 7 Tesla magnet for the University of Chicago MRI research scanner Role: Principal Investigator |
|
R21CA116939 (KARCZMAR, GREGORY S)Jul 1, 2005 - Dec 31, 2008 NIH Dynamic Spatial and Spectral, Contrast Enhanced MRI of * Role: Principal Investigator |
|
R21CA100996 (KARCZMAR, GREGORY S)May 1, 2005 - Apr 30, 2007 NIH Microvessel Density With High Spectral/Spatial MRI Role: Principal Investigator |
|
R01EB003108 (KARCZMAR, GREGORY S)Sep 15, 2003 - Jul 31, 2008 NIH High Spectral/Spatial Resolution Imaging Breast Cancer Role: Principal Investigator |
|
R21CA089408 (KARCZMAR, GREGORY S)Apr 1, 2002 - Mar 31, 2005 NIH High Spectral &Spatial Resolution MRI of Rodent Tumors Role: Principal Investigator |
|
S10RR015687 (KARCZMAR, GREGORY S)Apr 1, 2001 - Jun 30, 2002 NIH UPGRADE FOR 4.7 TESLA MR SCANNER Role: Principal Investigator |
|
R01CA078803 (KARCZMAR, GREGORY S)Sep 1, 1999 - Feb 28, 2009 NIH Fast Spectroscopic MR Imaging of Breast Cancer Role: Principal Investigator |
|
R01CA075476 (KARCZMAR, GREGORY S)Sep 1, 1999 - Jun 30, 2003 NIH EFFECTS OF RADIOSENSITIZERS MEASURED BY MRI Role: Principal Investigator |
|
R29CA052008 (KARCZMAR, GREGORY S)Jan 18, 1991 - Dec 31, 1996 NIH RESPONSE OF TUMORS TO TNF STUDIED BY MAGNETIC RESONANCE Role: Principal Investigator |
|
F32DK007770 (KARCZMAR, GREGORY S)Aug 1, 1986 NIH THE CONTROL OF AMP DEAMINASE IN VIVO, USING 3IP NMR Role: Principal Investigator |